Austin Mark John has filed 3 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 34500 shares of Perspective Therapeutics, Inc. ($CATX) on July 17, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 17, 2024 | Perspective Therapeutics, Inc. | $CATX | Austin Mark John | VP Finance/Prin Fin&Acct Offic | A | Stock Option (right to buy) | 34500 | $0.00 | 34,500.0000 | 0 | 9999.99% | 0.00% |
| April 23, 2024 | Perspective Therapeutics, Inc. | $CATX | Austin Mark John | VP Finance/Prin Fin&Acct Offic | M | Common stock | 30000 | $0.36 | 84,030.0000 | 0 | 55.52% | 0.00% |
| April 23, 2024 | Perspective Therapeutics, Inc. | $CATX | Austin Mark John | VP Finance/Prin Fin&Acct Offic | M | Stock option (right to buy) | 30000 | $0.00 | 120,000.0000 | 0 | 20.00% | 0.00% |